CTOs on the Move

Medco Center Of Campbellsville

www.extendecare.com

 
Medco Center Of Campbellsville is a Campbellsville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

The AMERICAN ACADEMY OF PEDIATRICS, AZ Chapter

The AMERICAN ACADEMY OF PEDIATRICS, AZ Chapter is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The American Academy of Anesthesiologist Assistants

The American Academy of Anesthesiologist Assistants is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hollenbeck Home

Serving the Greater Los Angeles area for more than a century, men and women in their senior years have enjoyed Hollenbeck`s vibrant, rewarding and comfortable environment, where friendships grow as personal interests are pursued. Hollenbeck Palms offers independent residential living, assisted residential living and skilled nursing services. Please refer to the main menu to view each of these opportunities for aging-in-place. Give us a call to schedule a convenient time to visit and enjoy an escorted tour of our impressive facilities and a complimentary lunch in our Grand Dining Room.

Soul Community Planet

Soul Community Planet was born out of a vision to provide Holistic Hospitality experiences for individuals desiring to make positive choices for themselves and the planet. SCP Colorado Springs was the first concept unveiled in 2018 with SCP Redmond following in 2019 and SCP Depoe Bay in 2020.

Repertoire

Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.